Literature DB >> 28214109

A novel mutation in TREM2 gene causing Nasu-Hakola disease and review of the literature.

Efthimios Dardiotis1, Vasileios Siokas2, Eva Pantazi3, Maria Dardioti2, Dimitrios Rikos3, Georgia Xiromerisiou2, Aikaterini Markou3, Dimitra Papadimitriou2, Matthaios Speletas4, Georgios M Hadjigeorgiou5.   

Abstract

Nasu-hakola disease (NHD) is a rare disease characterized by bone cysts and fractures, frontal lobe syndrome, and progressive presenile dementia. NHD may be the prototype of primary microglial disorders of the CNS or, as they have been coined, "microgliopathies". Mutations in TREM2 and TYROBP genes are known to cause NHD. Interestingly, recent evidence-associated rare genetic variants of TREM2 gene with increased risk of Alzheimer's disease, frontotemporal dementia, amyotrophic lateral sclerosis, and Parkinson's disease. Here, we report a 33-year-old Greek female with phenotype suggestive of NHD. Full gene sequencing of the TREM2 and TYROBP genes revealed a novel mutation in exon 2 of TREM2 gene, namely c.244G>T (p.W50C) and heterozygosity in the parents and her brother. This report extends the range of TREM2 mutations that cause NHD phenotype. In addition, we provide a comprehensive review of all reported in the literature TREM2 gene mutations and the respective wide spectrum of clinical manifestations that highlights the importance of considering TREM2 gene mutations in a variety of neurodegenerative phenotypes.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Microgliopathies; Nasu-hakola disease; Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy; TREM2 gene mutations

Mesh:

Substances:

Year:  2017        PMID: 28214109     DOI: 10.1016/j.neurobiolaging.2017.01.015

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  21 in total

Review 1.  Developmental roles of microglia: A window into mechanisms of disease.

Authors:  Sarah R Anderson; Monica L Vetter
Journal:  Dev Dyn       Date:  2018-12-10       Impact factor: 3.780

2.  Osteoporosis and Dementia: Establishing a Link.

Authors:  Christine W Lary; Clifford J Rosen; Douglas P Kiel
Journal:  J Bone Miner Res       Date:  2021-09-19       Impact factor: 6.741

Review 3.  White matter microglia heterogeneity in the CNS.

Authors:  Sandra Amor; Niamh B McNamara; Emma Gerrits; Manuel C Marzin; Susanne M Kooistra; Veronique E Miron; Erik Nutma
Journal:  Acta Neuropathol       Date:  2021-12-08       Impact factor: 17.088

4.  Human Induced Pluripotent Stem Cell-Derived Microglia-Like Cells Harboring TREM2 Missense Mutations Show Specific Deficits in Phagocytosis.

Authors:  Pablo Garcia-Reitboeck; Alexandra Phillips; Thomas M Piers; Claudio Villegas-Llerena; Matt Butler; Anna Mallach; Celia Rodrigues; Charles E Arber; Amanda Heslegrave; Henrik Zetterberg; Harald Neumann; Stephen Neame; Henry Houlden; John Hardy; Jennifer M Pocock
Journal:  Cell Rep       Date:  2018-08-28       Impact factor: 9.423

Review 5.  Microglia in Neurodegenerative Events-An Initiator or a Significant Other?

Authors:  Gaylia Jean Harry
Journal:  Int J Mol Sci       Date:  2021-05-29       Impact factor: 5.923

6.  Differential regulation of TREM2 and CSF1R in CNS macrophages in an SIV/macaque model of HIV CNS disease.

Authors:  Audrey C Knight; Samuel A Brill; Clarisse V Solis; Morgan R Richardson; Megan E McCarron; Suzanne E Queen; Charles C Bailey; Joseph L Mankowski
Journal:  J Neurovirol       Date:  2020-06-02       Impact factor: 3.739

Review 7.  TREM2 in Neurodegenerative Diseases.

Authors:  Taylor R Jay; Victoria E von Saucken; Gary E Landreth
Journal:  Mol Neurodegener       Date:  2017-08-02       Impact factor: 14.195

8.  Functional Studies of Missense TREM2 Mutations in Human Stem Cell-Derived Microglia.

Authors:  Philip W Brownjohn; James Smith; Ravi Solanki; Ebba Lohmann; Henry Houlden; John Hardy; Sabine Dietmann; Frederick J Livesey
Journal:  Stem Cell Reports       Date:  2018-03-29       Impact factor: 7.765

9.  Microglia in Alzheimer's Disease: Activated, Dysfunctional or Degenerative.

Authors:  Victoria Navarro; Elisabeth Sanchez-Mejias; Sebastian Jimenez; Clara Muñoz-Castro; Raquel Sanchez-Varo; Jose C Davila; Marisa Vizuete; Antonia Gutierrez; Javier Vitorica
Journal:  Front Aging Neurosci       Date:  2018-05-11       Impact factor: 5.750

Review 10.  Genetic Risk Factors for Essential Tremor: A Review.

Authors:  Vasileios Siokas; Athina-Maria Aloizou; Zisis Tsouris; Ioannis Liampas; Paraskevi Aslanidou; Metaxia Dastamani; Alexandros G Brotis; Dimitrios P Bogdanos; Georgios M Hadjigeorgiou; Efthimios Dardiotis
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2020-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.